XML 31 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Organization, Nature of Business and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2017
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
 
 
Successor
 
 
Predecessor
 
 
 
March 31, 2017
 
 
December 31, 2016
 
Raw materials
  $
9,948
    $
16,367
 
Work-in-process
   
599
     
5,022
 
Finished goods
   
45,400
     
38,091
 
Total inventory
   
55,947
     
59,480
 
Inventory reserve
   
(461
)
   
(5,009
)
Inventory, net
  $
55,486
    $
54,471
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
 
 
Successor
 
 
Predecessor
 
 
 
Three Months Ended
March 31, 2017
 
 
On
January 1, 2017
 
 
Three Months Ended
March 31, 2016
 
   
(In thousands, except per
share amounts)
   
(In thousands, except per
share amounts)
 
Numerator:
                       
Net income (loss) attributed to common stockholders
  $
(32,301
)
  $
298,582
    $
(428,412
)
Denominator:
                       
Weighted average common shares outstanding
   
55,557
     
118,633
     
117,533
 
Effect of potentially dilutive common shares:
                       
Stock options
   
     
     
 
Restricted shares
   
     
     
 
Weighted average common shares outstanding and assumed conversions
   
55,557
     
118,633
     
117,533
 
Income (loss) per common share:
                       
Basic
  $
(0.58
)
  $
2.52
    $
(3.65
)
Diluted
  $
(0.58
)
  $
2.52
    $
(3.65
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
 
 
Successor
 
 
Predecessor
 
 
 
Three Months Ended
March 31, 2017
 
 
On
January 1, 2017
 
 
Three Months Ended
March 31, 2016
 
   
(In thousands)
   
(In thousands)
 
Basic loss per share:
                       
Restricted shares
   
299
     
898
     
2,726
 
Diluted loss per share:
                       
Anti-dilutive stock options
   
155
     
4,416
     
4,523
 
Anti-dilutive restricted shares
   
299
     
898
     
2,695
 
Potentially dilutive securities excluded as anti-dilutive
   
454
     
5,314
     
7,218